Global private equity firm Cathay Capital Private Equity has acquired a 25 percent stake in Cabio Bioengineering, a China-based biologically fermented foods producer. The transaction was structured through the Sino French (Midcap) Fund. The new investment will help the company to diversify its product portfolio and increase its market coverage. Financial details of the transaction were not disclosed.